NCT02679508 Vonoprazan Study in Patients With Erosive Esophagitis to Evaluate Long-term Safety Status COMPLETED Phase PHASE4
NCT02678676 An Observational Study of Patient Cohorts Who Previously Received Long-term Treatment With Pioglitazone or Placebo in Addition to Existing Antidiabetic Medications Status COMPLETED Phase N/A
NCT02669121 Efficacy and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-like Particle Vaccine in Adults Status COMPLETED Phase PHASE2
NCT02669082 The Exploratory Study to Investigate the Effect of Ramelteon for Insomnia Patients With Major Depressive Disorder by Using Actigraphy Status COMPLETED Phase PHASE4
NCT02661490 Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine in an Elderly Population Status COMPLETED Phase PHASE2
NCT02655237 A Phase 3 Study to Evaluate the Efficacy and Safety of Relugolix (TAK-385) 40 mg Compared With Leuprorelin in the Treatment of Uterine Fibroids Status COMPLETED Phase PHASE3
NCT02655224 A Placebo-Controlled, Phase 3 Study of Relugolix (TAK-385) 40 mg in the Treatment of Pain Symptoms Associated With Uterine Fibroids Status COMPLETED Phase PHASE3
NCT02651155 Lubiprostone for the Treatment of Chronic Idiopathic Constipation Status COMPLETED Phase PHASE3
NCT02646683 A Study to Evaluate Efficacy, of Early Versus Late Use of Vedolizumab in Crohn's Disease: the LOVE-CD Study Status COMPLETED Phase PHASE4
NCT02646657 An Open Label Phase 4 Study to Evaluate Efficacy of Early Versus Late Use of Vedolizumab in Ulcerative Colitis Status COMPLETED Phase PHASE4
NCT02637466 Vortioxetine for MDD, Cognition, and Systemic Inflammatory Biomarkers Status WITHDRAWN Phase PHASE4
NCT02630966 Vedolizumab IV 300 mg in the Treatment of Fistulizing Crohn's Disease Status COMPLETED Phase PHASE4
NCT02630030 Phase 0 Analysis of Ixazomib (MLN9708) in Patients With Glioblastoma Status COMPLETED Phase EARLY_PHASE1
NCT02629848 Study of Motesanib (AMG 706) in Combination With Paclitaxel and Carboplatin for Advanced Non-Squamous Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE3
NCT02622581 Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients Status RECRUITING Phase N/A
NCT02620046 A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease Status COMPLETED Phase PHASE3